Start here if you're new
what it is
B&G Foods sells pantry staples like spices, hot cereal, sauces, and snacks through a portfolio of old grocery-store brands.
how it gets paid
Last year B&G Foods made $1.8B in revenue. meals and sauces was the main engine at $0.50B, or 28% of sales.
why growth slowed
Revenue fell 5.4% last year. Year-to-year sales declined 5% due to volume losses from three divestitures that removed $10 million of sales from the third quarter.
what just happened
Quarterly EPS came in at $0.28, matching one data source's consensus but below another $0.32 estimate.
At a glance
C++ balance sheet — some cracks in the foundation
75/100 earnings predictability — reasonably predictable
8.4x trailing p/e — the market's not buying it — or you found a deal
16.4% dividend yield — cash in your pocket every quarter
12.0% return on capital — nothing to write home about
xvary composite: 35/100 — weak
What they do
B&G Foods sells pantry staples like spices, hot cereal, sauces, and snacks through a portfolio of old grocery-store brands.
This is not a fast-grower. It is a shelf-space business. B&G sells into the boring center of the grocery store, where repeat buys matter and 2,784 employees keep more than 30 brands on shelves. If your pantry already has the brand, switching is easy in theory and lazy in practice.
How they make money
$1.8B
annual revenue · their business grew -5.4% last year
spices and seasonings
$0.45B
+1.0%
meals and sauces
$0.50B
3.0%
breakfast and spreads
$0.34B
5.0%
snacks and bars
$0.27B
4.0%
canned and shelf-stable staples
$0.24B
6.0%
The products that matter
sells pantry staples and household products
Shelf-Stable Food & Household Products
$1.8B revenue · the whole company
It's the entire $1.8B business, and that total fell 5.4% last year. The snapshot does not break B&G into cleaner operating buckets, which tells you where to look instead. This is less a segment-allocation story than a debt, margin, and demand story.
100% of revenue
Key numbers
$2.0B
long-term debt
Debt → money owed for years → so what: B&G owes more than 5 times its roughly $375 million market value, so the balance sheet runs the story.
16.4%
dividend yield
Yield → annual cash payout versus stock price → so what: the market is pricing in stress, because healthy staples companies rarely need to offer this much income.
8.4x
trailing p/e
P/E → stock price divided by past earnings → so what: you are paying a low multiple, but that discount matches shrinking sales and heavy debt.
$5
18-month target
The 18-month target is just $5 versus today's $4.64, or about 8% upside. That tells you cheap is not the same as compelling.
Financial health
C++
strength
- balance sheet grade C++ — below average — limited financial resources
- risk rank 4 — safer than 20% of stocks
- price stability 25 / 100
- long-term debt $2.0B (84% of capital)
- net profit margin 4.1% — keeps 4 cents of every dollar in revenue
- return on equity 15% — $0.15 profit for every $1 investors have put in
C++ — balance sheet grade and long-term debt are flagged. this stock carries more risk than average.
Total return vs. market
You invested $10,000 in BGS 3 years ago → it's now worth $5,380.
The index would have given you $13,920.
source: institutional data · total return
What just happened
missed estimates
Quarterly EPS came in at $0.28, matching one data source's consensus but below another $0.32 estimate.
Full-year revenue fell 5.4% to $1.8 billion. Management said divestitures removed about $10 million of sales, but even excluding those deals, sales still fell 3%.
$1.8B
revenue
$0.28
eps
21.4%
gross margin
the number that mattered
The key number was the 5.4% annual revenue decline, because low-margin food companies cannot shrink and carry $2.0 billion of debt forever.
-
b&g foods stock continues to trade near its 52-week low.a mixed 2025 september-period report, coupled with the potential for ongoing divestitures, has kept the stock close to the moving average low price of $3.67 per share reached in early august.
-
year-to-year sales declined 5% due to volume losses from three divestitures that removed $10 million of sales from the third quarter.
-
when excluding recent divestitures, sales declined 3%, with decreases in all but the spices & flavors solutions unit.indeed, the packaged foods company has been making selective brand divestitures (see below) to solidify the core brand portfolio. meanwhile, earnings rose two pennies thanks to cost control efforts and productivity gains across a mexican manufacturing plant, despite commodity cost and tariff headwinds.
-
for the fourth quarter, snap benefit cutbacks from the government shutdown may have impacted retail channel sales.
-
all told, we are still anticipating full-year top- and bottom-line declines of 6% and 21%, respectively, to $1.83 billion and $0.55 a share.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
B&G's risk profile is not generic packaged-food risk. It is a shrinking revenue base sitting under $2.0B of debt with only a 2.6% net margin to absorb mistakes.
med
$2.0B of debt against a $375M equity value
This is the cleanest contrast on the page. Debt is 84% of capital, the balance sheet is graded C++, and the market value of the equity is small relative to the obligations sitting above it.
If earnings weaken again, debt stops being background context and becomes the thing shaping every capital-allocation decision.
med
sales erosion is still wider than the portfolio cleanup
Revenue fell 5.4% last year. Management said three divestitures removed $10M from the third quarter, but sales still fell 3% even excluding those deals, and most units moved lower.
If the top line keeps slipping, the stock does not get re-rated just because the p/e starts with an eight.
med
the dividend may be promising more than the business can comfortably support
A 16.4% yield looks generous until you remember where it came from. The stock price collapsed, full-year EPS fell from $0.70 to $0.55, and the latest quarter lost money.
If the payout loses credibility, income-focused holders lose the main reason to stay patient.
med
commodity costs, tariffs, and pressured consumers all hit a 2.6% margin fast
Management flagged commodity costs, tariff pressure, and possible SNAP-related retail weakness. When you only keep about 3 cents on each revenue dollar, small operating hits travel straight to the bottom line.
B&G does not need a crisis to disappoint you. One more stretch of soft demand and thin margins is enough.
The core risk is simple: if sales do not stabilize soon, the balance sheet keeps getting louder and the low multiple keeps making sense.
source: institutional data · regulatory filings · risk analysis
Pay attention to
key metric
revenue stabilization
Last year revenue was $1.8B, down 5.4%. If that line does not flatten, the rest of the turnaround story has nothing solid to stand on.
trend
divestitures versus underlying demand
Management can sell brands, but excluding divestitures sales still fell 3%. You want to see the core business stop shrinking on its own.
risk
dividend credibility
A 16.4% yield is not a normal staples income story. Watch whether earnings and cash back the payout, or whether the market's skepticism wins.
next report
quarterly margin
The latest quarter printed a -2.4% margin. If the next few reports stay below zero, balance-sheet pressure gets much harder to dismiss.
Analyst rankings
risk profile
below average
stability score 4 means it is safer than just 20% of stocks. in human-speak, this is not the sleepy staples name the category label suggests.
earnings predictability
75 / 100
The business is reasonably modelable even while performance is weak. Predictable does not mean healthy. Sometimes it just means the decline is easy to see.
valuation signal
8.4x p/e
That multiple tells you the market is not giving B&G much benefit of the doubt. Here's the thing: you are either buying a recovery before it is obvious or a value trap that still pays a dividend until it doesn't.
source: institutional data
Institutional activity
112 buyers vs. 137 sellers in 3q2025. total institutional holdings: 55.1M shares.
source: institutional data
Price targets
3-5 year target range
$3
$7
$5
current price
$5
target midpoint · +8% from current · 3-5yr high: $14 (+200% · 39% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive